GLIBENCLAMIDE (DOSE TO BE TITRATED FROM STARTING DOSE OF 5MG OM) PLUS ROSIGLITAZONE 4MG OM (INCREASED TO 8MG OM AFTER 6 MONTHS) AND VS GLIBENCLAMIDE (DOSE TO BE TITRATED WITH STARTING DOSE OF 5MG OM) PLUS PLACEBO, ADMINISTERED TO PATIENTS WITH TYPE 2 DIABETES MELLITUS: